---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009878"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:47:36.195059+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Inogen prelim Q4 rev ~$82M (+2% YoY); FY25 rev ~$349M (+4%); order delays into H1 2026

## Summary
- Q4 2025 preliminary revenue ~$82M, up ~2% YoY; full-year 2025 ~$349M, up ~4% YoY.
- Company expects to achieve positive Adjusted EBITDA for full-year 2025.
- Shift in timing of a few large customer orders from Q4 2025 to H1 2026 caused disappointment.
- Full-year highlights: launches of Voxi 5 concentrator and Aurora Masks in U.S.; revenue growth and progress toward profitability.
- Full Q4/FY2025 results and 2026 guidance to be announced on February 24, 2026.

## SEC filing metadata
- accession: 0001193125-26-009878
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000119312526009878/0001193125-26-009878-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000119312526009878/ingn-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009878
- JSON: https://secwatch.observer/filing/0001193125-26-009878.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009878.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.